Physician profile
Mani Tehranchi
NPI 1821045253
$2,130.90
in general payments reported to CMS, 2019-2025
25 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $449 · 2020: $360 · 2021: $363 · 2022: $492 · 2023: $107 · 2024: $361.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $468.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $467.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $668.03 | 2019-2024 | |
| Hologic Sales and Service, LLC | $181.10 | 2019-2024 | Thinprep 2000 Processor, Aptima, Affirm Prone Biopsy System |
| Coopersurgical, INC. | $167.29 | 2021-2022 | |
| Lupin INC. | $122.18 | 2019 | |
| Mayne Pharma Commercial LLC | $102.59 | 2023-2024 | |
| Astellas Pharma US INC | $98.95 | 2024 | Veozah |
| Bayer Healthcare Pharmaceuticals INC. | $98.11 | 2019-2022 | |
| Intuitive Surgical, INC. | $90.92 | 2019 | |
| Channel Medsystems, INC. | $80.64 | 2022 | |
| Organon LLC | $58.67 | 2022-2024 | |
| Baxter Healthcare | $47.62 | 2024 | Tisseel |
| Momentis Surgical INC. | $45.00 | 2022 | |
| Merck Sharp & Dohme LLC | $42.39 | 2019-2021 | |
| Daiichi Sankyo INC. | $42.33 | 2020-2021 | |
| Allergan, INC. | $40.98 | 2019 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myovant Sciences INC. | $39.03 | 2022 | |
| Therapeuticsmd, INC. | $38.84 | 2020-2021 | |
| Becton, Dickinson and Company | $35.72 | 2022 | |
| Agile Therapeutics, INC. | $25.18 | 2022-2023 | Twirla |
| Avion Pharmaceuticals | $23.48 | 2023 | Balcoltra |
| Minerva Surgical, INC | $20.14 | 2022 | |
| Mylan Pharmaceuticals INC. | $17.56 | 2021 | |
| Evofem Biosciences, INC. | $16.48 | 2022 | |
| Coloplast Corp | $14.87 | 2023 | Altis |
| Gynesonics, INC. | $12.80 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mani Tehranchi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.